Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. (Q50506114)
Jump to navigation
Jump to search
scientific article published on 12 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. |
scientific article published on 12 December 2011 |
Statements
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. (English)
1 reference
1 reference
Daniel C Javitt
1 reference
Larry J Seidman
1 reference
Michael F Green
1 reference
Donald C Goff
1 reference
Robert W Buchanan
1 reference
Jeffrey Lieberman
1 reference
Richard S E Keefe
1 reference
Robert Kern
1 reference
Robert P McMahon
1 reference
John G Csernansky
1 reference
Joseph P McEvoy
1 reference
Fred Jarskog
1 reference
James M Gold
1 reference
Karen S Nolan
1 reference
Deanna S Barch
1 reference
M Patricia Ball
1 reference
James Robinson
1 reference
Stephen R Marder
1 reference
12 December 2011
1 reference
136
1 reference
1-3
1 reference
25-31
1 reference
Identifiers
1 reference